Özdemir, Berna

Up a level
Export as [feed] RSS
Group by: Date | Item Type | Refereed | No Grouping
Jump to: 2022 | 2021


Özdemir, Berna C; Gerard, Camille L; Espinosa da Silva, Cristina (2022). Sex and gender differences in anticancer treatment toxicity - a call for revisiting drug dosing in oncology. (In Press). Endocrinology Endocrine Society 10.1210/endocr/bqac058

Hoffmann, Michèle; Hayoz, Stefanie; Özdemir, Berna C. (2022). Prescription Patterns, Recurrence, and Toxicity Rates of Adjuvant Treatment for Stage III/IV Melanoma-A Real World Single-Center Analysis. Biology, 11(3) MDPI 10.3390/biology11030422


Hoffmann, Michèle; Schardt, Julian; Ionescu, Codruta; Wolf-Schnurrbusch, Ute E.; Wagner, Franca; Dettmer, Matthias S.; Olariu, Radu; Özdemir, Berna C. (2021). Long lasting response to anti-PD-1 therapy of recurrent conjunctival squamous cell carcinoma - A case report and systematic review of the literature. Current problems in cancer: case reports, 4, p. 100088. Elsevier 10.1016/j.cpccr.2021.100088

Arangalage, Dimitri; Degrauwe, Nils; Michielin, Olivier; Monney, Pierre; Özdemir, Berna C. (2021). Pathophysiology, diagnosis and management of cardiac toxicity induced by immune checkpoint inhibitors and BRAF and MEK inhibitors. Cancer treatment reviews, 100, p. 102282. Elsevier 10.1016/j.ctrv.2021.102282

Arangalage, Dimitri; Pavon, Anna Giulia; Özdemir, Berna C; Michielin, Olivier; Schwitter, Jurg; Monney, Pierre (2021). Acute cardiac manifestations under immune checkpoint inhibitors-beware of the obvious: a case report. European heart journal - case reports, 5(8), ytab262. Oxford University Press 10.1093/ehjcr/ytab262

Ghisoni, E; Wicky, A; Bouchaab, H; Imbimbo, M; Delyon, J; Gautron Moura, B; Gérard, C L; Latifyan, S; Özdemir, B.C.; Caikovski, M; Pradervand, S; Tavazzi, E; Gatta, R; Marandino, L; Valabrega, G; Aglietta, M; Obeid, M; Homicsko, K; Mederos Alfonso, N N; Zimmermann, S; ... (2021). Late-onset and long-lasting immune-related adverse events from immune checkpoint-inhibitors: An overlooked aspect in immunotherapy. European journal of cancer, 149, pp. 153-164. Elsevier 10.1016/j.ejca.2021.03.010

Ma, Min; Ghosh, Soumitra; Tavernari, Daniele; Katarkar, Atul; Clocchiatti, Andrea; Mazzeo, Luigi; Samarkina, Anastasia; Epiney, Justine; Yu, Yi-Ru; Ho, Ping-Chih; Levesque, Mitchell P; Özdemir, Berna C.; Ciriello, Giovanni; Dummer, Reinhard; Dotto, G Paolo (2021). Sustained androgen receptor signaling is a determinant of melanoma cell growth potential and tumorigenesis. The Journal of experimental medicine, 218(2) Rockefeller Univ. Press 10.1084/jem.20201137

Özdemir, Berna C (2021). Immune checkpoint inhibitor-related hypogonadism and infertility: a neglected issue in immuno-oncology. Journal for immunotherapy of cancer, 9(2) BMJ Publishing Group 10.1136/jitc-2020-002220

Özdemir, Berna C. (2021). Androgen Signaling in the Tumor Microenvironment. In: Tumor Microenvironment, Advances in Experimental Medicine and Biology. Advances in Experimental Medicine and Biology: Vol. 1270 (pp. 169-183). Springer 10.1007/978-3-030-47189-7_10

Provide Feedback